PCM
FOLD

PenderFund Capital Management’s Amicus Therapeutics FOLD Stock Holding History

PenderFund Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41,100
Closed -$594K – 245
2026
Q1 		$594K Buy
41,100
+29,200
+245% +$419K 0.09% 69
2025
Q4 		$169K Buy
+11,900
New +$117K 0.03% 139

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

PenderFund Capital Management's FOLD Position: Q2 2026 in Review

PenderFund Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 41,100 shares — an estimated $594K sold.

PenderFund Capital Management first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $594K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • PenderFund Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • PenderFund Capital Management sold 41,100 Amicus Therapeutics shares in Q2 2026, an estimated $594K.
  • PenderFund Capital Management first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • PenderFund Capital Management's Amicus Therapeutics position peaked at $594K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on PenderFund Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.